Imbed Biosciences Revenue and Competitors

Madison, WI USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Imbed Biosciences's estimated annual revenue is currently $8.5M per year.(i)
  • Imbed Biosciences's estimated revenue per employee is $243,829

Employee Data

  • Imbed Biosciences has 35 Employees.(i)
  • Imbed Biosciences grew their employee count by -8% last year.

Imbed Biosciences's People

NameTitleEmail/Phone
1
VP R&DReveal Email/Phone
2
Chief Scientific and Quality OfficerReveal Email/Phone
3
Purchasing ManagerReveal Email/Phone
4
ControllerReveal Email/Phone
5
Research EngineerReveal Email/Phone
6
Production SupervisorReveal Email/Phone
7
Level 2 Lead OperatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4M32-6%$50.6MN/A
#2
$18.1M55-7%N/AN/A
#3
$23.3M9829%N/AN/A
#4
$72.5M2890%N/AN/A
#5
$7.3M2713%N/AN/A
#6
$28.1M1128%N/AN/A
#7
$104.4M257-25%N/AN/A
#8
$12.3M497%N/AN/A
#9
$51.7M1849%N/AN/A
#10
$12.3M39-2%N/AN/A
Add Company

What Is Imbed Biosciences?

Imbed Biosciences Inc. is a privately held medical device company emerging as a leader in the development of advanced therapies for the treatment of burns, chronic ulcers, gastro-intestinal defects, and soft-tissue repair. The company has a portfolio of products in development based on its patented MicroLyte® Matrix technology that presents bioactive molecules on tissue surfaces to combat local pain and infections. The microscale matrix accelerates cell migration and reduces antibiotic/opioid abuse. Company is registered with U.S. FDA as a medical device manufacturer and maintains an ISO 13485 certified Quality Management System. For more information, please visit www.imbedbio.com, www.MicrolyteMatrix.com, facebook.com/imbedbio, and follow @ImbedBio and @MicroLyteAgMtrx on twitter.

keywords:N/A

N/A

Total Funding

35

Number of Employees

$8.5M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7M35-12%N/A
#2
$5.4M3521%N/A
#3
$7.4M35-3%N/A
#4
$9.1M35-3%N/A
#5
$3.9M356%N/A